Monashee Investment Management LLC Invitae Corp Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$17.37 - $26.27 $2.17 Million - $3.28 Million	-125,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.65 - $25.75 $1.33 Million - $3.22 Million	125,000 New	125,000 $2.93 Million
Q2 2018 Aug 10, 2018	SELL	$4.87 - $8.42 $2.02 Million - $3.49 Million	-415,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$4.69 - $10.05 $1.95 Million - $4.17 Million	415,000 New	415,000 $1.95 Million
Q4 2017 Feb 09, 2018	SELL	$7.86 - $9.99 $830,605 - $1.06 Million	-105,675 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$8.89 - $10.4 $939,450 - $1.1 Million	105,675	105,675 $990,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.